No decision yet on J&J Covid-19 vaccine, top SA adviser says

13 April 2021 - 17:42 By Alexander Winning
subscribe Just R20 for the first month. Support independent journalism by subscribing to our digital news package.
Subscribe now
The US regulatory authority recommended a pause in the rollout of Johnson & Johnson's Covid-19 vaccine to investigate a very rare blood clotting disorder but SA hasn't made a decision yet. File photo.
The US regulatory authority recommended a pause in the rollout of Johnson & Johnson's Covid-19 vaccine to investigate a very rare blood clotting disorder but SA hasn't made a decision yet. File photo.
Image: Dado Ruvic/Reuters

South Africa has not yet taken a decision on how to proceed with Johnson & Johnson's Covid-19 vaccine, a top government adviser said, after US health agencies recommended pausing use of the vaccine because of rare cases of blood clots.

The Ministerial Advisory Committee on vaccines would "be looking at all the issues shortly," the committee's chair Barry Schoub told Reuters. South Africa has vaccinated almost 290,000 healthcare workers with the J&J vaccine in an ongoing research study.

Reuters


subscribe Just R20 for the first month. Support independent journalism by subscribing to our digital news package.
Subscribe now